Breaking News: After brushing off Biogen, Sage finds buyer for $795M

Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow Cambridge biotech Biogen Inc.

BREAKING NEWS After brushing off Biogen, Sage finds buyer for $795M Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow Cambridge biotech Biogen Inc. READ MORE RELATED NEWS FDA cites 'resource constraints' in delay of local biotech's approval Five BIO 2025 events you don't want to miss From Kentucky farm to founding Biogen: Film traces life of Phil Sharp Meet the woman who helped make Mass. life sciences great Alnylam, GSK, Vertex pledge hundreds of Mass. jobs for tax incentives View as Webpage   Unsubscribe | Manage Preferences   All rights reserved. ©  Boston Business Journal Email sent by Boston Business Journal 70 Franklin Street, 8th Floor Boston, MA 02110 USA Download the free app for breaking news alerts on your phone